Clinical PhD Student
- Research Group Home Page:
- Work address:
- Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
POSEIDON phase 1b results: safety, efficacy and ctDNA response of taselisib combined with tamoxifen in hormone receptor positive metastatic breast cancer patients.
E-pub date: 31 Jul 2019
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer.
E-pub date: 31 Aug 2018
Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine Resistance.
E-pub date: 31 Dec 2017
- Show allHide all